HIV disease progression correlates with the generation of dysfunctional naive CD8low T cells

D Favre, CA Stoddart, B Emu, R Hoh… - Blood, The Journal …, 2011 - ashpublications.org
D Favre, CA Stoddart, B Emu, R Hoh, JN Martin, FM Hecht, SG Deeks, JM McCune
Blood, The Journal of the American Society of Hematology, 2011ashpublications.org
HIV infection can result in depletion of total CD4+ T cells and naive CD8+ T cells, and in the
generation of dysfunctional effector CD8+ T cells. In this study, we show that naive CD8+ T
cells in subjects with progressive HIV disease express low levels of CD8α and CD8β chains.
Such naive CD8low T cells display broad signaling defects across the T-cell receptor
complex, and their appearance correlates with generalized up-regulation of major
histocompatibility complex class I (MHC-I) antigens on peripheral blood mononuclear cells …
Abstract
HIV infection can result in depletion of total CD4+ T cells and naive CD8+ T cells, and in the generation of dysfunctional effector CD8+ T cells. In this study, we show that naive CD8+ T cells in subjects with progressive HIV disease express low levels of CD8α and CD8β chains. Such naive CD8low T cells display broad signaling defects across the T-cell receptor complex, and their appearance correlates with generalized up-regulation of major histocompatibility complex class I (MHC-I) antigens on peripheral blood mononuclear cells (PBMCs). To explore a causal link between increased MHC-I up-regulation and the generation of naive CD8low T cells, we used the humanized SCID-hu Thy/Liv mouse model to show that HIV infection of the thymus and interferon α (IFNα) treatment alone result in MHC-I up-regulation and in the generation of dysfunctional CD3highCD8+CD4 single-positive 8 (SP8) thymocytes with low expression of CD8. We suggest that dysfunctional naive CD8low T cells are generated as a result of IFNα-mediated up-regulation of MHC-I on stromal cells in the thymus and antigen-presenting cells in the periphery, and that dysfunction in this naive compartment contributes to the immunodeficiency of HIV disease. This study is registered at www.clinicaltrials.gov as NCT00187512.
ashpublications.org